PM
CTMX icon

Prosight Management’s CytomX Therapeutics CTMX Stock Holding History

Prosight Management’s Portfolio CTMX Stock Details CTMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$7.98M Sell
3,517,113
-412,895
-11% -$937K 1.95% 17
2025
Q1 		$2.5M Buy
3,930,008
+25,008
+0.6% +$15.9K 0.82% 27
2024
Q4 		$4.02M Buy
3,905,000
+882,891
+29% +$909K 1.11% 22
2024
Q3 		$3.57M Buy
+3,022,109
New +$3.57M 0.88% 28